Immunocyte phenotype and breast cancer risk: A Mendel randomization analysis

Area of Science:

• Immunology
• Genetics
• Oncology

Background:

• Breast cancer is a major global health concern.
• Understanding immune system's role in breast cancer etiology is critical.
• Mendelian randomization (MR) is used to explore immune cell features and breast cancer risk.

Purpose of the Study:

• To investigate the causal relationship between immune cell phenotypes and breast cancer risk.
• To identify specific immune cell features that may influence breast cancer development.
• To explore the immunological underpinnings of breast cancer etiology.

Main Methods:

• Two-sample Mendelian randomization (MR) analysis.
• Utilized genome-wide association studies (GWAS) data from 257,730 Europeans (17,389 cases, 240,341 controls).
• Examined 731 immune cell features across 7 groups, employing inverse variance weighting (IVW) and weighted median estimation.

Main Results:

• Identified 20 immunophenotypes with significant causal associations with breast cancer risk.
• Observed positive and negative correlations for B cell, mature T cell, T + B + NK (TBNK) cells, regulatory T (Treg) cells, classic dendritic cells (cDCs), monocytes, and myeloid cell groups.
• Reverse MR analysis indicated no significant causal effect of breast cancer on these immune characteristics.

Conclusions:

• The study highlights a complex interplay between immune cell phenotypes and breast cancer risk.
• Identified immunophenotypes may serve as potential biomarkers or therapeutic targets.
• Findings deepen the understanding of breast cancer's immunological aspects.